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Abstract
Rationale: Catecholamine-producing tumors are rare, occurring in less than 0.2% of patients with hypertension, but can have
relevant cardiovascular morbidity and mortality.
Patient concerns: A 37-year-old woman presented with a history of dyspnea, chest pain, palpitations, and paroxysmal
hypertension. Electrocardiogram, echocardiogram, and cardiac magnetic resonance showed severe LVH with a prevalent
involvement of the anterior portion of interventricular septum. Endomyocardial biopsy found severe hypertrophy with disarray of
cardiomyocytes and ultrastructural evidence of contraction and necrosis of myocytes. Hormone investigations revealed high values
of 24-hours urinary metanephrines. Abdominal computed tomography (CT) showed an enlarged left adrenal gland with a strong
uptake of 123I—metaiodobenzylguanidine at scintigraphy scan.
Interventions: Thus, the adrenal tumor was surgically removed.
Outcomes: At follow-up examination, the patient’s metanephrines levels were normalized and the transthoracic echocardiogram
showed a reduction of LVH.
Diagnosis and lessons:We report a rare case of catecholamine–induced cardiomyopathy due to an adrenal adenoma mixed
with nodules enriched in epinephrine-types secreting granules.
Abbreviations: 123I—MIBG = 123I—Metaiodobenzylguanidine, BP = blood pressure, CT = computed tomography, DXM =
dexamethasone, HCM= hypertrophic cardiomyopathy, HR= heart rate, IVS = interventricular septum, LV= left ventricle, LVEF = left
ventricular ejection fraction, LVH = left ventricular hypertrophy, MR = magnetic resonance, PHEO = Pheochromocytoma, SAM =
systolic anterior motion.
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1. Introduction
Pheochromocytoma (PHEO), literally “tumor that is colored
with salts chromium”, is a rare neuroendocrine neoplasm
arising from chromaffin cells, which is typically found in the
adrenal medulla.[1] The PHEOs originate from sympathetic
nervous system, synthetize and secrete catecholamines and their
metabolites. Clinical presentation is characterized by extreme
variability, and most frequent symptoms are palpitations,
headaches, and diaphoresis, associated with high blood pressure
values.[2,3]
The cardiovascular effects of the excessive catecholaminergic
states can range from mild to dramatic or catastrophic.
Compared to individuals with essential hypertension, those with
PHEO have a 14-fold higher rate of cardiovascular events,
including myocardial infarction, stroke, and cardiomyopathy.[4]
In particular, PHEO has been attributed to cause types of
cardiomyopathies, including peri-partum, dilated, Takotsubo,
and hypertrophic forms.[5] It has been suggested that PHEO-
related cardiomyopathy is caused by the excessive levels of
plasmatic catecholamines, which are released from the tumor.[5]
However, the precise histological features of reversible cardio-
myopathy in PHEO-patients are today not completely known. In
this paper, we report a rare case of a patient with hypertrophic
cardiomyopathy (HCM) due to an adrenal adenoma mixed with
nodules enriched in adrenaline-types secretory granules.
2. Case report
A 37-year-old woman with a history of arterial hypertension and
cutaneous 3B-follicolar lymphoma presented with a history of
dyspnea, chest pain, palpitations, and paroxysmal hypertension.
Her current medications included irbesartan and hydrochloro-
thiazide. On admission, her blood pressure (BP) values were 170/
100 mm Hg and her heart rate (HR) was 70beats/min and
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regular. Her respiratory rate was 20breaths/min and her lungs
were clear at the auscultation. The electrocardiogram (ECG)
showed sinus rhythm; there were signs of left ventricular
hypertrophy (LVH) with negative T waves in lateral leads, V5
and V6. The plasma proBNP concentration was 87pg/mL, which
was in normal range (normal values<100pg/ml). Other data,
including electrolytes, troponin, creatinine kinase, creatinine
were within the normal range. The chest X-ray film no revealed
enlargement of the cardiac silhouette. A 2D transthoracic
echocardiogram showed a dilatation of the left atrium (24
cm2) with severe LVH (end-diastolic intraventricular septum
thickness—17mm) and preserved left ventricular ejection
fraction (LVEF—60%). Suspecting the presence of a cardiomy-
opathy a cardiac magnetic resonance (MR) imaging with
gadolinium was performed and showed symmetric LVH with
a prevalent involvement of the anterior portion of interventricu-
lar septum. A minimum left ventricular outflow obstruction was
reported without an atypical systolic anterior motion of the
mitral valve. A supposed diagnosis of HCM was made (Fig. 1).
Heart muscle impairment was investigated by cardiac catheteri-
zation and angiography. Coronary angiography revealed no
coronary artery stenosis. Catheterization was followed by a left
ventricle endomyocardial biopsy extracting 4 fragments, which
were processed for histology and electron microscopy. At the left
ventricle endomyocardial biopsy myocytes demonstrated fea-
tures of hypercontraction of myofilaments with formation of
contraction bands and occasional cellular necrosis. Wide
intracellular and perivascular fibrosis was seen. A significant
number of arterioles showed thickened tunica with resulting
vessel lumen reduction. Further, the endocardium was thickened
with prominence of smooth muscle cells (Fig. 2). An electron
microscopy showed at higher magnification the catecholamine-
induced diffuse contraction band necrosis. This data was
suggestive of catecholamine-induced LVH (Fig. 2).
A hormonal screening test for secondary arterial hypertension
revealed an abnormal increase of 24-hours urinary metanephrines
Figure 1. Cardiac magnetic resonance (MR) showing moderate symmetric left ventricular hypertrophy (LVH), which mostly involves the anterior section of
interventricular septum (IVS) in its basal and medial part (sectal thickness of anterior-basal part is 19mm; inferior-basal part is 14mm; anterior-medial part is 16mm;
inferior-basal part is 14mm), in basal portion of anterior wall (thickness 18mm) and in middle portion of lateral wall (thickness 16mm). The remaining part of
myocardium has a thickness between 10 and 15mm. This hypertrophy is responsible for a mild tightening/obstruction of the left ventricular outflow tract and a
modest acceleration of flow, without an atypical systolic anterior motion of the mitral valve (SAM). Mild aortic andmitral valve regurgitation can been seen. LVH = left
ventricular hypertrophy, IVS = interventricular septum, MR = magnetic resonance.
Figure 2. Microscopic findings of biopsy specimen from the endomyocardium of left ventricle showing markedly hypertrophied fibers, contraction bands and
replacement fibrosis.
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(396 and 421mg/24h; normal values 2–350mg/24h) suggesting
the presence of a PHEO (Table 1). A computed tomography
(CT) scan showed an enlargement of the left adrenal gland
with globe shape. The strongest uptake of 123I—Metaiodoben-
zylguanidine (123I—MIBG) by the left adrenal lesionwas observed
in 123I—MIBG scintigraphy (Fig. 3).
Pre-operative management was begun with fluids and alpha-
adrenergic receptor blockers, resulting in BP control. The patient
underwent left laparoscopic adrenalectomy with no significant
hemodynamic alterations during the procedure. The adrenal
glandmeasured 3.5x2.5x 2.0cm and it had an altered profile due
to the presence of a yellow nodule surrounded by a subtle fibrous
capsule. Nodule was made of 2 cell populations arranged in nests
of trabeculae: 1 minor cell line had eosinophilic granular
cytoplasm, the other had clear vacuolated cytoplasm. The
remaining left adrenal gland showed areas of cortical hyperplasia
(Fig. 4). On the basis of these findings a histological diagnosis of
cortical adenoma with adrenocortical hyperplasia was primarily
made. Secondly, immunohistochemical staining revealed diffused
positivity for synaptophysin and chromogranin. At electron
microscopy the tumor cells contained lipid vacuoles and smooth
endoplasmic reticulum, consisted with adrenocortical differenti-
ation, along multiple intracytoplasmatic adrenaline-type, dense
core neurosecretory granules (Fig. 5).
Considering these results a diagnosis of adrenocortical
adenoma with mixed nodules enriched in adrenaline-type
secretory granules was made.
The patient was discharged medicated with irbesartan 150mg/
day, amlodipine 5mg/day, and hydrochlorothiazide 12.5mg/day.
At 6 months follow up, the patient’s 24-hours urinary
metanephrines levels were normalized (143mg/24h) and the
transthoracic echocardiography after surgery showed a reduction
of end-diastolic intraventricular septum thickness (14mm)
(Table 2) associated to normalization of BP values (130/80
mm Hg).
3. Discussion
This is a unique case, to our knowledge, of a catecholamine-
induced HCM induced by a cortical adrenal adenoma with
Figure 3. Scintigraphy with 123I-metaiodobenzilguanidine (123I—MIBG) showed raised activity within the left adrenal gland, concordant with the mass.
Table 1
Endocrinological data of the patient at diagnosis and after laparoscopy surgical treatment.
At diagnosis After surgery Normal values
PLASMA
Plasma renin activity 2.0 2.7 0.2–2.7 ng/mL/h
Plasma aldosterone concentration 141 207 30–160 pg/mL
Plasma cortisol 9 11.1 4.5–21mg/dL
Plasma cortisol post-overnight DXM-test 12 – <50 pg/mL
URINE
Free cortisol 126.3 78.3 58–403mg/24h
Urine aldosterone concentration 19.0 30.7 2.8–34mg/24
Metanephrines 396; 421
∗
143 0–350mg/24h
Vanillyl mandelic acid 6.7; 5.1
∗
3.2 1–10mg/24h
DXM=dexamethasone: 1mg at 11:00 pm
∗
Second sample collection
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adrenaline-neurosecretory granules inside. The appearance of
these metabolites, stored into nodules enriched in multiple
secretory granules, explains the strongest uptake of the left
adrenal lesion in 123I-MIBG scintigraphy. Previously, false-
positive results of MIBG imaging were reported in adrenal
adenomas showing augmented tracer uptake.[6,7,8] We support
that our case cannot be listed in those previously described
because we demonstrated, by using electron microscopy, the
existence of a complex network of neurosecretory granules, that
are directly responsible of this clinical scenario.
Left ventricular endomyocardial biopsy has been crucial, in
this case, to testify catecholamine-induced LVH. Use of
endomyocardial biopsy in HCM is still controversial and is
recommended only in infiltrative or storage diseases.[9] In patients
with true HCM, left ventricular endomyocardial biopsy can be
specifically useful to analyze the underlying causes of cardiac
deterioration,[10] to demonstrate histological changes during the
course of the disease, and finally to provide myocardial tissue for
research purposes.[11]
Catecholamine-induced cardiomyopathy is defined by a
reversible left ventricular dysfunction without evidence of
obstructive coronary artery disease. Acute and chronic myocar-
dial damage are the results of an exogenous or endogenous
catecholamine excess.
Overactivation of the sympatho-adrenergic system is an
essential process to support cardiovascular system during
stressful conditions in critical illnesses.[12] Although, its pro-
longed and excessive stimulation is detrimental to cardiovascular
system. Abnormal amounts of catecholamines, via the beta-1
adrenoceptor transduction pathway, induce directly intracellular
calcium overload in cardiomyocytes.[13] Furthermore, these
metabolites can also indirectly damage the heart, in particular
via their oxidation during stressful situations, which generate
oxygen radicals that provoke coronary artery spasm, arrhyth-
mias and cardiac dysfunction.[14] On the other hand, long-term
exposure to catecholamines down-regulate the expression of
beta-adrenergic receptors, inducing the suboptimal function of
myofibers and decreasing the number of contracting units. As the
consequent result, PHEO-associated cardiomyopathy is histo-
logically characterized by contraction band necrosis, neutrophil
infiltration, and fibrosis.[15]
Similar mechanisms of myocardial toxicity, which originate
from a hyper catecholaminergic state, have been described in case
of cocaine abuse, including marked oxidative stress and
mitochondrial dysfunction. Instead, chronic use of cocaine
may results in various degrees of systolic and diastolic
dysfunction, cardiac hypertrophy and dilatation.[16] Histological
features, such as in those cases of endogenous excess of
Figure 4. Immunohistochemical staining for synaptophysin in cortical adrenal
gland specimen.
Figure 5. Electron microscopy showed neurosecretory granules in cortico-
medulla nodules.
Table 2
Comparison of 2D Echocardiographic features before and 6 months after laparoscopy surgical treatment.
At diagnosis After surgery
Left Ventricle (LV) posterior wall thickness in diastole (mm) 13.0 12.2
Interventricular septum (IVS) thickness in diastole, (mm) 17.0 15.0
Systolic anterior motion of the mitral valve (SAM) Absent Absent
Mitral regurgitation Mild Absent
Mean LV outflow gradient (mm Hg) 35 22
Ejection fraction (%) 60 60
IVS = Interventricular septum, LV = Left Ventricle, SAM = Systolic anterior motion.
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catecholamines, include loss of myofibrils, multiple foci of band
contraction necrosis and fibrosis.[17]
Treatment of PHEO-associated cardiomyopathy is curative
surgical resection of catecholamine-producing tumor. After the
appropriate excision of PHEO, cardiomyopathy may definitely
reverse.[18]
In summary, we have described a rare case of catecholamine–
induced cardiomyopathy due to an adrenal adenoma mixed with
nodules enriched in epinephrine-type secreting granules. The
patient has provided informed consent for publication of this case
report.
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